Recombinant CD274 (Atezolizumab Biosimilar) antibody (Alexa Fluor 405)
This Humanized Monoclonal antibody specifically detects CD274 (Atezolizumab Biosimilar) in FACS, ELISA and CyTox. It exhibits reactivity toward Human.
Quick Overview for Recombinant CD274 (Atezolizumab Biosimilar) antibody (Alexa Fluor 405) (ABIN7766361)
Target
CD274 (Atezolizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Conjugate
This CD274 (Atezolizumab Biosimilar) antibody is conjugated to Alexa Fluor 405
Application
Flow Cytometry (FACS), ELISA, Cytotoxicity Test (CyTox)
-
-
Purpose
-
Conjugated Anti-PDL1 (atezolizumab biosimilar) mAb
-
Purification
-
Purified from cell culture supernatant by affinity chromatography
-
-
-
Application Notes
-
most applications: 1: 50 - 1: 250
-
Restrictions
-
For Research Use only
-
-
Buffer
-
Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.
-
Preservative
-
Sodium azide
-
Precaution of Use
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
-
Protect from light!
-
Storage
-
4 °C
-
Storage Comment
-
Store at 4°C in dark for 6 months
-
Target
-
CD274 (Atezolizumab Biosimilar)
-
Alternative Name
-
atezolizumab biosimilar
-
Target Type
-
Biosimilar
-
Background
-
PD-L1, CD274, B7-H1, PDCD1L1, PDCD1LG1
-